Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2022 | Bringing novel agents to the frontline setting in myeloma

In this video, Mattia D’Agostino, MD, University of Turin, Turin, Italy, shares some insights into current and future treatment approaches in multiple myeloma, and the excitement around bringing novel agents to the frontline setting. Dr D’Agostino also highlights treatment options for transplant-eligible and elderly patients, and concludes by mentioning the promise of immunotherapies, including CAR-T therapy and bispecific antibodies. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.